Vimkunya, Injektionssuspension in einer Fertigspritze

7680704900016 CH-70490 Injektionssuspension

Associated product:

VIMKUNYA susp inj 40 µg 1 pce

No image available

Article details

Package size
1
Selling units
1
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
09/05/2026
Summary of Product Characteristics
Français
09/05/2026
Summary of Product Characteristics
Italien
09/05/2026

Detailed composition

Substance Quantity Type Category
trosovavilpum alfa
40.0 UG Substance Wirkstoff (Principe actif)
aluminii hydroxidum hydricum ad adsorptionem
- Substance HNIDK
saccharum
- Substance HNIDK
dikalii phosphas anhydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.4 MG Substance HBESI
kalium
0.44 MG Substance HBESI

Authorization holder

Bavarian Nordic Berna GmbH

3098 Köniz

Authorization information

Swissmedic authorization number
70490
Drug name
Vimkunya, Injektionssuspension in einer Fertigspritze
Galenic form
INJFS
ATC Code
J07BP02
Authorization status
Z
Dispensing category
B
First authorization
15/04/2026
Authorization expiration date
14/04/2031
IT Number
08.08.
Domain
Human medicine
Field of application
Zur aktiven Immunisierung von Personen ab 12 Jahren zur Prävention einer Erkrankung, die durch das Chikungunya-Virus (CHIKV) verursacht wird.

Package details

Description (FR)
VIMKUNYA susp inj 40 µg 1 pce
Description (DE)
VIMKUNYA Inj Susp 40 µg 1 Stk
Market launch
22/06/2026
Narcotic (BTM)
No
Buy us a coffee Explore the data